The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses by Giorgio Santoni et al.
“ﬁmmu-04-00034” — 2013/2/13 — 11:04 — page 1 — #1
REVIEW ARTICLE
published: 14 February 2013
doi: 10.3389/ﬁmmu.2013.00034
The role of transient receptor potential vanilloid type-2 ion
channels in innate and adaptive immune responses
Giorgio Santoni1*,Valerio Farfariello1,2, Sonia Liberati 1,3, Maria B. Morelli 1, Massimo Nabissi 1,
Matteo Santoni4 and Consuelo Amantini 1
1 Section of Experimental Medicine, School of Pharmacy, University of Camerino, Camerino, Italy
2 Department of Urology and Andrology, University of Perugia, Perugia, Italy
3 Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
4 Department of Medical Oncology, Polytechnic University of the Marche Region, Ancona, Italy
Edited by:
Masaaki Murakami, Osaka University,
Japan
Reviewed by:
Daisuke Kamimura, Osaka University,
Japan
Hideki Ogura, Osaka University, Japan
*Correspondence:
Giorgio Santoni, Section of
Experimental Medicine, School of
Pharmacy, University of Camerino,
Via Madonna delle Carceri 9,
62032 Camerino, Italy.
e-mail: giorgio.santoni@unicam.it
The transient receptor potential vanilloid type-2 (TRPV2), belonging to the transient receptor
potential channel family, is a specialized ion channel expressed in human and other
mammalian immune cells. This channel has been found to be expressed in CD34+
hematopoietic stem cells, where its cytosolic Ca2+ activity is crucial for stem/progenitor
cell cycle progression, growth, and differentiation. In innate immune cells, TRPV2 is
expressed in granulocytes, macrophages, and monocytes where it stimulates fMet-Leu-
Phe migration, zymosan-, immunoglobulin G-, and complement-mediated phagocytosis,
and lipopolysaccharide-induced tumor necrosis factor-alpha and interleukin-6 production. In
mast cells, activation of TRPV2 allows intracellular Ca2+ ions ﬂux, thus stimulating protein
kinase A-dependent degranulation. In addition,TRPV2 is highly expressed in CD56+ natural
killer cells. TRPV2 orchestrates Ca2+ signal in T cell activation, proliferation, and effector
functions. Moreover, messenger RNA for TRPV2 are expressed in CD4+ and CD8+ T
lymphocytes. Finally, TRPV2 is expressed in CD19+ B lymphocytes where it regulates
Ca2+ release during B cell development and activation. Overall, the speciﬁc expression
of TRPV2 in immune cells suggests a role in immune-mediated diseases and offers new
potential targets for immunomodulation.
Keywords: transient receptor potential, transient receptor potential vanilloid type-2, macrophages, mastocytes,
T cell activation, B cell activation, immuno-mediated-diseases, immunomodulation
TRPV2: A MEMBER OF THE TRP CHANNEL FAMILY
The 30 mammalian transient receptor potential (TRP) cation
channels identiﬁed so far can be sorted into seven subfamilies:
TRPC (canonical), TRPM (melastatin), TRPV (vanilloid), TRPA
(ankyrin transmembrane protein), TRPP (polycystin), TRPML
(mucolipin), and TRPN (NomPC-like). TRPs are essentially clas-
siﬁed according to their primary amino acid sequence rather than
selectivity or ligand afﬁnity. From a structural standpoint, TRP
channels are membrane proteins with six putative transmembrane
spans (TMs) anda cation-permeable pore region formedby a short
hydrophobic stretchbetweenTM5andTM6(Owsianik et al., 2006;
Figure 1). TRPproteins are essentially cation-permeable ion chan-
nels sensitive to a remarkable range of stimuli. Genetic approaches
in worms, ﬂies, and mice have demonstrated the involvement of
TRPs in a variety of sensory processes that include thermosensa-
tion, osmosensation, olfaction, taste, mechanosensation, vision,
and pain perception. Remarkably, mutations in different TRPs
have also been linked to human diseases (Nilius et al., 2007).
Among TRPV channels, TRPV2 is a non-selective cation
channel showing Ca2+ permeability (Caterina et al., 1999). Its
activation triggers an inward cation current (mainly Ca2+) that
mediates a relatively broad repertoire of physiological functions in
response to noxious heat, with an activation threshold of >52◦C,
as well as to changes in osmolarity and membrane stretch.
Human TRPV2 (hTRPV2) channel is triggered by agonists such as
Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD;
Neeper et al., 2007; Qin et al., 2008; Nabissi et al., 2013). It
was found to be expressed both in the plasma membrane and
early endosome. Activation of TRPV2 by growth factors causes
PI-3K-dependent and independent translocation in the plasma
membrane (Kanzaki et al., 1999; Penna et al., 2006). In addition,
TRPV2 may serve as an endosomal calcium release channel that
controls endosome fusion and/or exocytosis (Saito et al., 2007; Abe
and Puertollano, 2011). It has been demonstrated that TRPV2
expression and activity are increased following inﬂammation, by
the action of growth factors such as insulin-like growth factor I
(IGF-I; Shimosato et al., 2005). However, the contribute of TRPV2
to inﬂammation requires further investigations.
This work summarizes data reported in the literature on the
expression and function of TRPV2 in hematopoietic stem cells
(HSCs) and in natural and adaptive immune cells (Table 1).
EXPRESSION OF TRPV2 IN HSCs
Stem cells are found in all multi-cellular organisms and are char-
acterized by the ability to self-renew through mitotic cell division
and differentiate into a range of specialized cell types. Multi-
ple functional ion channel currents have been reported to be
heterogeneously present in different types of stem cells. They
include the voltage-gated delayed rectiﬁer K+ current (IKDR), the
Ca2+-activated K+ current (KCa), inward rectiﬁer K+ current,
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FIGURE 1 | Alignment and comparison of humanTRPVs amino acid structure, highlighting the known functional domains and the potential
phosphorylation sites. PKA, protein kinase A; PKC, protein kinase C; TK, tyrosine kinase.
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Table 1 | Role ofTRPV2 in immune cells.
Cell type Species TRPV2-mediated
effect
Reference
Neutrophils Human Migration Heiner et al. (2003)
Monocytes/
macrophages
Mouse Migration Nagasawa et al. (2007)
Mouse Phagocytosis Link et al. (2010)
Mouse Cytokine production? Yamashiro et al. (2010)
Mouse Differentiation Kajiya et al. (2010)
Mast cells Human Degranulation Zhang et al. (2012)
T cells Human T cell receptor and
Ca2+ signaling
Sauer and Jegla (2006)
hyperpolarization-activated cyclic nucleotide regulated cation
current, chloride current, voltage-gated Na+ current, L-type
calcium current, and TRP non-selective cation currents (Li and
Deng, 2011).
While these channels are key players in the pathophysiology of
excitable cells, a wide variety of ion channels are also expressed by
non-excitable cells, such as cells of the immune system, where they
function in signalingpathways regulating electrolyte transport, cell
volume, proliferation, differentiation, and apoptosis.
CD34+ HSCs give rise to all types of blood cells from the
myeloid (monocytes, neutrophils, erythrocytes, dendritic cells,
etc.) and lymphoid lineages [T cells, B cells, and natural killer
(NK) cells].
Cytosolic Ca2+ activity is crucial for stem/progenitor cell cycle
progression and growth (Ferreira-Martins et al., 2009; Resende
et al., 2010). Primary human CD34+ HSCs express voltage-gated
K+ channels, two-pore domain background K+ channels, and
TRP non-selective cation channel family. By using ﬂuorescent-
activated cell sorting (FACS) and reverse transcriptase-polymerase
chain reaction (RT-PCR), it has been found that human
CD34+/CD45+/CD133+CD73− HSCs express TRPV2 channels
(Park et al., 2011). Despite the limitation in applying higher tem-
perature conditions, a 42◦C TRPV2-like current was consistently
observed in CD34+ HSCs. These data are in accordance with
the previously reported transcriptoma analysis evaluated by GNF
gene expression (Su et al., 2004) suggesting a peculiar expres-
sion of TRPV2 mRNA in CD34+ HSCs (Figure 2). Recently,
we have demonstrated, both at mRNA and protein levels, that
human neural stem cells (NSCs) and glioblastoma stem-like cells
(GSCs) express TRPV2 (Morelli et al., 2012), as reminiscence of
the primitive myeloid progenitors (Ginhoux et al., 2010).
TRPV2 CHANNELS IN CELLS OF NATURAL IMMUNITY
Innate immunity, also called natural or native immunity, con-
sists of cellular and biochemical defense mechanisms in place
before infection and poised to respond rapidly to infections. The
natural immune system includes cells of both myeloid and lym-
phoid origin, monocytes, macrophages, granulocytes, dendritic
cells, and mastocytes as well as NK cells. These cells express
many channels belonging to the TRP channel family. Among
these, we focused our attention on the expression and function of
TRPV2.
GRANULOCYTES
Immune cells kill microbes by engulﬁng them in a membrane-
enclosed compartment, the phagosome. Phagocytosis is initiated
when foreign particles bind to receptors on the membrane of
phagocytes. The best-studied phagocytic receptors, those for
immunoglobulins (FcγR) and for complement proteins (CR),
activate phospholipase C (PLC) and D (PLD), resulting in the
intracellular production of Ca2+. The molecules that medi-
ate Ca2+ ion ﬂux across the phagosomal membrane are still
unknown but likely include the ubiquitous store-operated Ca2+
entry (SOCE) channels, ligand-gated chloride channel (LGCC),
voltage-gated Ca2+ channel (VGCC), and TRP channels.
TRPV2 mRNA has been demonstrated in human neutrophil
granulocytes by RT-PCR (Heiner et al., 2003). In these cells,
TRPV2 seems to be of particular importance for the response to
chemoattractants, suggesting a role in leukocyte migration.
MONOCYTES AND MACROPHAGES
TRPV2 gene expression data identify mRNA expression in human
CD33+ myeloid cells and CD14+ monocytes. RT-PCR and
immunoblot analyses have shown that TRPV2 is the sole member
of the TRPV family expressed in mouse macrophages (Yamashiro
et al., 2010), both in whole blood and in inﬂammatory tissues such
as mouse peritoneal macrophages (Kim et al., 2003) and mouse
osteoclasts (Kajiya et al., 2010). In addition, TRPV2 is expressed
in human alveolar macrophages (Kowase et al., 2002).
It has been recently demonstrated (Nagasawa et al., 2007) that
the chemotactic peptide fMet-Leu-Phe (fMLP) is able to promote
the migration of mouse TtT/M87 macrophages by inducing the
translocation of TRPV2 channels. This effect was blocked by an
inhibitor of PI3-kinase, LY294002, and pertussis toxin. More-
over, treatment with serum-induced translocation of TRPV2 to
the plasma membrane is blocked by transfection of short-form
TRPV2 (s-TRPV2) lacking a pore-forming region and the sixth
transmembrane domain. In experiments using whole-cell patch
clamp, the Ca2+ current in TtT/M87 cells was blocked by the TRP
channels inhibitor ruthenium red and transfection of either s-
TRPV2 or siRNA for TRPV2. fMLP induced a rapid and sustained
elevation of cytoplasmic Ca2+, that was abolished by removal
of extracellular calcium, ruthenium red, and transfection of s-
TRPV2 or siRNA-TRPV2. Finally, fMLP-induced migration of
macrophages was blocked by ruthenium red or transfection of
s-TRPV2.
A role of TRPV2 in early phagocytosis and its fundamental
importance in innate immunity was demonstrated in mice by
Link et al. (2010). They showed that zymosan-, immunoglobulin
G (IgG)-, and complement-mediated particle binding and phago-
cytosis were impaired in macrophages lacking TRPV2 channels.
TRPV2 was recruited to the nascent phagosome and depolarized
the plasma membrane. This event increased the synthesis of phos-
phatidylinositol 4,5-bisphosphate, which triggered partial actin
depolymerization necessary for occupancy-elicited phagocytic
receptor clustering (Figure 3). TRPV2-deﬁcient macrophages
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FIGURE 2 | Gene expression pattern of theTRPV2 gene. Diagram created by AndrewGNF based on data from Su et al. (2004).
were also defective in chemoattractant-elicited motility. Finally,
TRPV2-deﬁcient mice showed accelerated mortality and greater
organ bacterial load when challenged with Listeria monocytogenes.
Several studies have indicated that intracellularCa2+ is a second
messenger in Toll-like receptor 4 (TLR4)-dependent signaling.
Recently, a role of TRPV2 in lipopolysaccharide (LPS)-induced
cytokine mRNA production in mouse macrophages has been
demonstrated (Yamashiro et al., 2010). Thus, shRNA against
TRPV2 inhibited the LPS-induced mRNA for tumor necro-
sis factor-alpha (TNF-α) and interleukin (IL)-6 and induced
inhibitor of nuclear factor-kappaB (NF-κB) alpha (IkBα) degra-
dation. Experiments using 1,2-bis-(o-Aminophenoxy)-ethane-
N,N,N′,N′-tetraacetic acid, tetraacetoxymethyl ester (BAPTA/AM)
and ethylene glycol tetraacetic acid (EGTA), and Ca2+ imag-
ing indicated that LPS-induced increase in [Ca2+]i involves both
TRPV2-mediated intracellular and extracellular Ca2+ mobiliza-
tions. In addition to Ca2+ mobilization through the IP3-receptor,
TRPV2-mediated intracellular Ca2+ mobilization is involved in
NF-κB-dependent TNF-α and IL-6 expression, while extracellular
Ca2+ entry is involved in NF-κB-independent IL-6 production.
Another study carried out in TRPV2-knockout (KO) mice (Link
et al., 2010) indicates that TRPV2 is not required for LPS-evoked
TNF-α protein release. The discrepancy between these two studies
could reside in the transcriptional (Yamashiro et al., 2010) or post-
transcriptional mechanisms involved in the regulation of cytokine
induction.
Recently, it has been demonstrated that the receptor activator of
NF-κB ligand (RANKL) induces TRPV2 expression and regulates
mouse osteoclast differentiation (osteoclastogenesis) via calcium
oscillations and activation of the nuclear factor of activated T cells
1 (NFATc1; Kajiya et al., 2010). Ca2+ oscillations are a prerequisite
for NFAT-dependent transcription. A possible source of Ca2+ for
calcineurin activation would be Ca2+ entry through TRP chan-
nels involved the so-called “store-operated Ca2+ entry.” By using
a DNA microarray, we found that TRPV2 channels are expressed
signiﬁcantly in RANKL-treated RAW264.7 cells (preosteoclasts)
compared to untreated cells. RANKL up-regulates TRPV2 expres-
sion in preosteoclasts, evokes spontaneous Ca2+ oscillations, and
a time-dependent transient inward cation current. The TRPV
inhibitor ruthenium red and tetracycline-induced TRPV2 silenc-
ingdecreasedboth the frequencyof Ca2+ oscillations and transient
inward currents in RANKL-treated preosteoclasts. Furthermore,
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FIGURE 3 | A model for the involvement ofTRPV2 in phagocytosis. (A)
Engagement of oligomeric ligands with receptors in the absence of obvious
receptor clustering leads to activation ofTRPV2 in a PI(3)K-dependent manner,
which results in membrane depolarization. How signals downstream of PI(3)K
activate TRPV2 remains unclear. Phosphorylation of TRPV2, oligomerization of
TRPV2, or recruitment of TRPV2 from intracellular compartment may trigger
TRPV2 activation. (B) PtdIns(4,5)P2 (PI(4,5)P2) is synthesized by a
combination of type II PI(4)K activated by membrane polarization and PIP(5)Kγ
activated by Syk. PtdIns(4,5)P2 recruits actin-binding proteins for local actin
depolymerization to change local plasma membrane ﬂuidity, thus allowing
FcγRs to move. (C) Higher order FcγR clustering strengthens the
FcγR-mediated signaling, resulting in the activation of PIP(5)Kα and the
generation of more PtdIns(4,5)P2, which is sufﬁcient for actin polymerization
with the aid ofWiskott–Aldrich syndrome protein (WASp) and Arp2/3. Actin
polymerization induces pseudopodia and phagosomal cup formation.
PtdIns(4,5)P2, FcγR, andTRPV2 are concentrated in the phagosomal cup. PI,
phosphoinositide; PI(4)P, phosphatidylinositol-4-phosphate; PI(3,4,5)P3,
phosphatidylinositol-3,4,5-trisphosphate; PKC, protein kinase C; ER,
endoplasmic reticulum. From Koyasu (2010). Copyright 2010 Nature
Publishing Group.
suppression of TRPV2 also reduced RANKL-induced NFATc1
expression, its nuclear translocation and osteoclastogenesis.
DENDRITIC CELLS
At present very few data have been provided on the expression of
TRPV2 in dendritic cells in human. TRPV2 gene expression was
identiﬁed in human dendritic cells, but no functional data have
been provided so far (Su et al., 2004).
NK CELLS
TRPV2 gene is 10- to 30-foldmore expressed inhumanCD56+ NK
cells compared to all the other cells of both innate and adaptive
systems (Su et al., 2004). Although this very high expression of
TRPV2 in NK cells is of great interest, the role of these channels
is still unknown. In rats, administration of 2.5 mg/kg of a TRPV2
agonist, CBD, increased the total number of NK cells and their
percentage (Ignatowska-Jankowska et al., 2009). Finally, on the
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basis of Link et al. (2010) data obtained in mouse, a role of TRPV2
in natural and antibody-dependent cytotoxicity of NK cells may
be hypothesized.
MAST CELLS
Mast cells are tissue-resident immune effector cells. They respond
to diverse stimuli by releasing potent biological mediators into the
surrounding tissue, and initiating inﬂammatory responses that
promote wound healing and infection clearance. In addition to
stimulation via immunological routes, mast cells also respond to
polybasic secretagogues and physical stimuli. Each mechanism for
mast cell activation relies on the inﬂux of calcium through speciﬁc
ion channels in the plasma membrane (Turner et al., 2007).
The expression, surface localization, and oligomerization of
TRPV2 protein subunits together with functional coupling of
TRPV2 protein to calcium ﬂuxes and proinﬂammatory degran-
ulation events have been reported in mast cells (Stokes et al.,
2004; Freichel et al., 2012). In addition, a novel protein kinase
A (PKA)-dependent signaling module containing PKA and a
putative A kinase adapter protein, acyl CoA binding domain-
containing protein 3 (ACBD3), that interacts with TRPV2, has
been demonstrated in human mast cells (Stokes et al., 2004).
A characteristic of TRPV2 is its activation by high noxious
temperature; temperatures exceeding 50◦C induced a ruthenium
red-sensitive current. In addition, laser light of 640 nm or light at
48 mW for 20 min induced current sensitive to SKF96365, a selec-
tive inhibitor of receptor-mediated Ca2+ entry and voltage-gated
Ca2+ entry. Thus, all the three physical stimuli able to activate
theTRPV2 channel-inducedpronounceddegranulation in human
mast cells, which could be blocked by ruthenium red or SKF96365.
Activation of TRPV2 allows Ca2+ ions to enter the cell, which in
turn induce degranulation, suggesting that TRPV2 plays a key role
in mast cell degranulation in response to mechanical, heat, and
red laser light stimulation (Zhang et al., 2012).
TRPV2 CHANNELS IN ADAPTIVE IMMUNITY
T LYMPHOCYTES
Calcium acts as a second messenger in many cell types, including
lymphocytes. Resting lymphocytes maintain a low concentration
of Ca2+ (Cahalan and Chandy, 2009; Vig and Kinet, 2009). A net-
work of six distinct types of ion channels, namely Kv1.3, KCa3.1,
olfactory receptor class A related 1 (Orai1), stromal interact-
ing molecule 1 (STIM1), Ca2+ release activating Ca2+ (CRAC)
channel, TRPV7 and TRPV2, orchestrates T cell activation, pro-
liferation, and effector functions, offering potential targets for
immunomodulation (Sauer and Jegla, 2006; Cahalan and Chandy,
2009). Most recently, TRPV2 has been found to cluster at the
immunological synapse following contact with antigen-presenting
cells, together with Kv1.3, KCa3.1, STIM1, and Orai1 channels
(Sauer and Jegla, 2006; Lioudyno et al., 2008; Cahalan andChandy,
2009). In regard to TRPV2, Sauer and Jegla (2006) have reported
that knockdown of TRPV2 in T cells impairs T cell receptor (TCR)
and calcium signaling. Speciﬁcally, in Jurkat cells nucleofected
with shDNA against hTRPV2, a defect in TCR or thapsigargin-
induced calcium mobilization, with predominant effect on the
sustained phase of calcium inﬂux, has been reported. Similar to
the effect induced by the knockdown of Lck (lymphocyte-speciﬁc
protein tyrosine kinase shDNA), an essential mediator of TCR
signaling, hTRPV2 shDNA transfected cells displayed a reduction
in store release, indicative of impaired conformational coupling
between CRAC channels and IP3 receptors (Cui et al., 2002).
In addition, dominant negative hTRPV2 inhibits endogenous
channels mediating Ca2+ inﬂux (Sauer and Jegla, 2006).
By quantitative RT-PCR (qRT-PCR), TRPV2 mRNA was
detected in whole peripheral blood, primary human T cells
(Saunders et al., 2007; Schwarz et al., 2007), CD4+ and CD8+
T cells (Spinsanti et al., 2008). In rats, administration of the
speciﬁc TRPV2 agonist, CBD, at a dose of 5 mg/kg caused
a signiﬁcant fall in T cells and T helper (Th) and cytotoxic
T (Tc) lymphocyte subsets (Ignatowska-Jankowska et al., 2009).
Moreover, CBD decreased the constitutive production of IL-
8, macrophage inﬂammatory protein 1 alpha (MIP-1α and β),
and Rantes, and phorbol ester stimulated production of TNF-
α, granulocyte-macrophage colony-stimulating factor (GM-CSF),
and interferon-gamma (IFN-γ) by human NK cells (Srivastava
et al., 1998). In addition, exposure of humanTcells THCdecreased
steady-state levels of mRNA encoding for Th1 cytokines, while
increasing mRNA levels for Th2 cytokines (Yuan et al., 2002).
B LYMPHOCYTES
At present, the literature offers very little information on the
expression of TRPV2 mRNA and protein in human. Using GNF
gene analysis, the expression of TRPV2 mRNA was found in whole
blood, lymph nodes and tonsils, and human CD19+ B lympho-
cytes (Su et al., 2004). These data were recently conﬁrmed by Boyd
et al. (2009), who used qRT-PCR, immunoﬂuorescence and FACS
analysis to demonstrate both at mRNA and protein levels the
expression of TRPV2 in normal human CD19+ B lymphocytes
and CD138+ plasma cells.
Information about the expression and function of TRPV2
in B lymphocytes was provided by Kanzaki et al. (1999) on
growth factor-regulated channel (GRC). It has been shown to be
79.4% identical to mouse TRPV2 (mTRPV2) at the amino-acidic
sequence. GRC belongs to the TRP channel family (mTRPV2)
localizes mainly in intracellular pools under basal conditions.
Upon stimulation of cells by IGF-I,GRC translocates to the plasma
membrane. Thus, IGF-I augments calcium entry through GRC by
regulating trafﬁcking of the channel (Kanzaki et al., 1999).
Overall, it is conceivable that TRPV2 acts as a transmem-
brane protein expressed on the surface of B cells, and that it
negatively controls Ca2+ ﬂux-activated proliferative signal trans-
duction pathways and B cell activation at immunological synaptic
level. Thus, the inhibitory role showed by TRPV2 in in vivo B
cell number, could be the result of CBD-induced translocation of
TRPV2 from the cytosol to the plasma membrane (Kanzaki et al.,
1999; Ignatowska-Jankowska et al., 2009; Morelli et al., 2012). In
the same view, the structural and functional similarity of mTRPV2
with CD20, a calcium permeable cation channel involved in B cell
activation (Bubien et al., 1993; Tedder and Engel, 1994; Figure 4)
and the inhibition of human embryonic kidney 293 (HEK-293)
cell proliferation induced by TRPV2 transfection, further support
this hypothesis (Penna et al., 2006; Nabissi et al., 2010).
It has also been suggested that TRPV2 plays an important role
in regulating Ca2+ release during B cell development. Thus, the
Frontiers in Immunology | Inﬂammation February 2013 | Volume 4 | Article 34 | 6
“ﬁmmu-04-00034” — 2013/2/13 — 11:04 — page 7 — #7
Santoni et al. TRPV2 in immune responses
FIGURE 4 | A model for the involvement ofTRPV2 B cell activity
regulation. (A) In normal conditions, B cell receptor (BCR) activation
induces calcium channels translocation and activation, resulting result
in B cell activation and proliferation. (B) Growth factors or cytokines, by
inducing PI(3)K-dependent or independent pathways, may induceTRPV2
translocation and activation, resulting in calcium overload, B cell activation
shut-down and induction of pro-apoptotic cell death pathways, in a similar
way to CD20.
promoter of TRPV2 shows binding sites for regulatory transcrip-
tion factors such as AP2rep, NF-AT1, NF-AT2, and NF-AT3 as well
as for Bach-2 (Su et al., 2004), which is critical for class switch
recombination and somatic hypermutation of immunoglobulin
genes (Muto et al., 2004).
TRPV2 channel has been found to be associated with the
recombinase gene activator protein during biosynthesis and early
trafﬁcking; it has been observed that over-expression of RGA pro-
tein potentiates basal surface localization of TRPV2 and cyclic
adenosine monophosphate (cAMP) signal in human non-sensory
cells (Barnhill et al., 2004; Stokes et al., 2005). In developing B
cells, expression of surface immunoglobulin is an important sig-
nal to terminate recombinase activator gene (RAG) expression and
V(D)J recombination. Cannabinoids play a critical role in B cell
activation and maturation, and the direct role of these compounds
in inducing B cell class switching from IgM to IgE has been demon-
strated in mice (Agudelo et al., 2008), however, the role of TRPV2
has not been addressed so far.
CONCLUSION
The TRPV2 is a specialized ion channel expressed in mam-
malian innate and adaptive immune system. Recent ﬁndings on
the TRPV2-mediated migration and phagocytosis of granulo-
cytes and macrophages, PKA-dependent mast cell degranulation
and its hypothesized role in NK cell cytotoxicity, strongly sug-
gest a major role played by TRPV2 in the control of innate
immune responses. Moreover, research on the involvement of
TRPV2 as negative transductor in T and B cell activation is still at
the beginning. One recent ﬁnding is the expression of TRPV2
in a chronic inﬂammatory skin diseases of unknown etiology
called erythematotelangiectatic and papulopustular rosacea (Sulk
et al., 2012).
Genetic approaches are required to advance a causal under-
standingon the role of TRPV2 in inﬂammatory immune-mediated
diseases and cancer. These approaches include over-expression
of dominant negative variants, antisense oligonucleotides, and
siRNA.
Moreover, although the search for natural TRPV2 ligands and
chemical modulators as therapeutic agents has been intensiﬁed in
the last years (e.g., synthetic and endogenous cannabinoids), spe-
ciﬁc agonists or blockers and a speciﬁc monoclonal anti-hTRPV2
antibody are still lacking.
Further study should be performed to completely address the
role of TRPV2 in the pathophysiology of the immune system.
ACKNOWLEDGMENT
Thisworkwas supportedby theAssociazione Italianaper laRicerca
sul Cancro (AIRC) National Grant 2011–2013 (Number 11095).
REFERENCES
Abe, K., and Puertollano, R. (2011).
Role of TRP channels in the reg-
ulation of the endosomal pathway.
Physiology 26, 14–22.
Agudelo, M., Newton, C., Widen,
R., Sherwood, T., Nong, L.,
Friedman, H., et al. (2008). Cannabi-
noid receptor 2 (CB2) mediates
immunoglobulin class switching
from IgM to IgE in culture of
murine-puriﬁed B lymphocytes. J.
Neuroimmune Pharmacol. 3, 35–42.
Barnhill, J. C., Stokes, A. J., Koblan-
Huberson, M., Shimoda, L. M.,
Muraguchi, A., Adra, C. N., et al.
(2004). RGA protein associates
with a TRPV ion channel during
biosynthesis and trafﬁcking. J. Cell.
Biochem. 91, 808–820.
Boyd, R. S., Jukes-Jones, R., Walewska,
R., Brown, D., Dyer, M. J., and
Cain, K. (2009). Protein proﬁling
of plasma membranes deﬁnes aber-
rant signaling pathways in mantle cell
lymphoma. Mol. Cell. Proteomics 8,
1501–1515.
Bubien, J. K., Zhou, L. J., Bell, P.
D., Frizzell, R. A., and Tedder, T.
F. (1993). Transfection of the CD20
cell surface molecule into ectopic cell
types generates a Ca2+ conductance
found constitutively in B lympho-
cytes. J. Cell Biol. 121, 1121–1132.
Cahalan, M. D., and Chandy, K.
G. (2009). The functional network
www.frontiersin.org February 2013 | Volume 4 | Article 34 | 7
“ﬁmmu-04-00034” — 2013/2/13 — 11:04 — page 8 — #8
Santoni et al. TRPV2 in immune responses
of ion channels in T lymphocytes.
Immunol. Rev. 231, 59–87.
Caterina, M. J., Rosen, T. A., Tomi-
naga, M., Brake, A. J., and Julius,
D. (1999). A capsaicin-receptor
homologue with a high thresh-
old for noxious heat. Nature 398,
436–441.
Cui, J., Bian, J. S., Kagan, A.,
and McDonald, T. V. (2002).
CaT1 contributes to the stores-
operated calcium current in Jurkat
T-lymphocytes. J. Biol. Chem. 277,
47175–47183.
Ferreira-Martins, J., Rondon-Clavo,
C., Tugal, D., Korn, J. A., Rizzi,
R., Padin-Iruegas, M. E., et al.
(2009). Spontaneous calcium oscil-
lations regulate human cardiac pro-
genitor cell growth. Circ. Res. 105,
764–774.
Freichel, M., Almering, J., and
Tsvilovskyy, V. (2012). The role
of TRP proteins in Mast cells.
Front. Immunol. 3:150. doi: 10.3389/
ﬁmmu.2012.00150
Ginhoux, F., Greter, M., Leboeuf, M.,
Nandi, S., See, P., Gokhan, S.,
et al. (2010). Fate mapping analy-
sis reveals that adult microglia derive
from primitive macrophages. Science
330, 841–845.
Heiner, I., Eisfeld, J., and Lückhoff, A.
(2003). Role and regulation of TRP
channels in neutrophil granulocytes.
Cell Calcium 33, 533–540.
Ignatowska-Jankowska, B., Jankowski,
M., Glac, W., and Swiergel, A. H.
(2009). Cannabidiol-induced lym-
phopenia does not involve NKT and
NK cells. J. Physiol. Pharmacol. 60,
99–103.
Kajiya, H., Okamoto, F., Nemoto, T.,
Kimachi,K., Toh-Goto,K.,Nakayana,
S., et al. (2010). RANKL-induced
TRPV2 expression regulates osteo-
clastogenesis via calcium oscillations.
Cell Calcium 48, 260–269.
Kanzaki, M., Zhang, Y. Q., Mashima,
H., Li, L., Shibata, H., and
Kojima, I. (1999). Translocation
of a calcium-permeable cation
channel induced by insulin-like
growth factor-I. Nat. Cell Biol. 1,
165–170.
Kim, C. S., Kawada, T., Kim, B. S.,
Han, I. S., Choe, S. Y., Kurata, T.,
et al. (2003). Capsaicin exhibits anti-
inﬂammatory property by inhibiting
IkB-a degradation in LPS-stimulated
peritoneal macrophages. Cell. Signal.
15, 299–306.
Kowase, T., Nakazato, Y., Yoko-O,
H., Morikawa, A., and Kojima, I.
(2002). Immunohistochemical local-
ization of growth factor-regulated
channel (GRC) in human tissues.
Endocr. J. 49, 349–355.
Koyasu, S. (2010). Vanilloid ﬂavor for
a good appetite? Nat. Immunol. 11,
187–189.
Li, G. R., and Deng, X. L.
(2011). Functional ion channels in
stem cells. World J. Stem Cells 3,
19–24.
Link, T. M., Park, U., Vonakis, B. M.,
Raben, D. M., Soloski, M. J., and
Caterina, M. J. (2010). TRPV2 has
a pivotal role in macrophage parti-
cle binding and phagocytosis. Nat.
Immunol. 11, 232–239.
Lioudyno, M. I., Kozak, J. A., Penna,
A., Safrina, O., Zhang, S. L., Sen, D.,
et al. (2008). Orai and STIM1 move
to the immunological synapse and
are up-regulated during T cell acti-
vation. Proc. Natl. Acad. Sci. U.S.A.
105, 2011–2016.
Morelli, M. B., Nabissi, M., Amantini,
C., Farfariello, V., Ricci-Vitiani, L., di
Martino, S., et al. (2012). The tran-
sient receptor potential vanilloid-2
cation channel impairs glioblastoma
stem-like cell proliferation and pro-
motes differentiation. Int. J. Cancer
131, E1067–E1077.
Muto, A., Tashiro, S., Nakajima, O.,
Hoshino, H., Takahashi, S., Sakoda,
E., et al. (2004). The transcriptional
programme of antibody class switch-
ing involves the repressor Bach2.
Nature 429, 566–571.
Nabissi, M., Morelli, M. B., Aman-
tini, C., Farfariello, V., Ricci-Vitiani,
L., Caprodossi, S., et al. (2010).
TRPV2 channel negatively controls
glioma cell proliferation and resis-
tance to Fas-induced apoptosis in
ERK-dependent manner. Carcino-
genesis 31, 794–803.
Nabissi, M., Morelli, M. B., Santoni, M.,
and Santoni, G. (2013). Triggering
of the TRPV2 channel by cannabid-
iol sensitizes glioblastoma cells to
cytotoxic chemotherapeutic agents.
Carcinogenesis 34, 48–57.
Nagasawa, M., Nakagawa, Y., Tanaka,
S., and Kojima, I. (2007). Chemo-
tactic peptide fMetLeuPhe induces
translocation of the TRPV2 channel
in macrophages. J. Cell. Physiol. 210,
692–702.
Neeper, M. P., Liu, Y., Hutchinson, T.
L., Wang, Y., Flores, C. M., and
Qin, N. (2007). Activation properties
of heterologously expressed mam-
malian TRPV2: evidence for species
dependence. J. Biol. Chem. 282,
15894–15902.
Nilius, B., Owsianik, G., Voets, T., and
Peters, J.A. (2007). Transient receptor
potential cation channels in disease.
Physiol. Rev. 87, 165–217.
Owsianik, G., D’Hoedt, D., Voets, T.,
and Nilius, B. (2006). Structure–
function relationship of the TRP
channel superfamily. Rev. Physiol.
Biochem. Pharmacol. 156, 61–90.
Park, K. S., Pang, B., Park, S. J., Lee,
Y. G., Bae, J. Y., Park, S., et al.
(2011). Identiﬁcation and functional
characterization of ion channels in
CD34(+) hematopoietic stem cells
from human peripheral blood. Mol.
Cells 32, 181–188.
Penna, A., Juvin, V., Chemin, J.,
Compan, V., Monet, M., and
Rassendren, F. A. (2006). Pl3-kinase
promotes TRPV2 activity indepen-
dently of channel translocation to the
plasma membrane. Cell Calcium 39,
495–507.
Qin, N., Neeper, M. P., Liu, Y., Hutchin-
son, T. L., Lubin, M. L., and Flores,
C. M. (2008). TRPV2 is activated
by cannabidiol and mediates CGRP
release in cultured rat dorsal root
ganglion neurons. J. Neurosci. 28,
6231–6238.
Resende, R. R., Adhikari, A., da Costa,
J. L., Lorençon, E., Ladeira, M.
S., Guatimosim, S., et al. (2010).
Inﬂuence of spontaneous calcium
events on cell-cycle progression in
embryonal carcinoma and adult stem
cells. Biochim. Biophys. Acta 1803,
246–260.
Saito, M., Hanson, P. I., and Schlesinger,
P. (2007). Luminal chloride-
dependent activation of endosome
calcium channels. Patch clamp study
of enlarged endosomes. J. Biol. Chem.
282, 27327–27333.
Sauer, K., and Jegla, T. J. (2006).
Methods for Identifying T Cell Activa-
tion Modulating Compounds. Patent
Application WO/2006/065613.
Saunders, C. I., Kunde, D. A., Craw-
ford, A., and Geraghty, D. P.
(2007). Expressionof transient recep-
tor potential vanilloid 1 (TRPV1)
and 2 (TRPV2) in human peripheral
blood. Mol. Immunol. 44, 1429–1435.
Schwarz, E. C., Wolfs, M. J., Tonner,
S., Wenning, A. S., Quintana, A.,
Griesemer, D., et al. (2007). TRP
channels in lymphocytes. Handb.
Exp. Pharmacol. 179, 445–456.
Shimosato, G., Amaya, F., Ueda, M.,
Tanaka, Y., Decosterd, I., and Tanaka,
M. (2005). Peripheral inﬂamma-
tion induces up-regulation of TRPV2
expression in rat DRG. Pain 119,
225–232.
Spinsanti, G., Zannolli, R., Panti, C.,
Ceccarelli, I., Marsili, L., Bachiocco,
V., et al. (2008). Quantitative real-
time PCR detection of TRPV1-4 gene
expression in human leukocytes from
healthy and hyposensitive subjects.
Mol. Pain 4, 51.
Srivastava, M. D., Srivastava, B. I., and
Brouhard, B. (1998). Delta9 tetrahy-
drocannabinol and cannabidiol alter
cytokine production by human
immune cells. Immunopharmacology
40, 179–185.
Stokes, A. J., Shimoda, L. M., Koblan-
Huberson, M., Adra, C. N., and
Turner, H. (2004). TRPV2-PKA sig-
naling module for transduction of
physical stimuli in mast cells. J. Exp.
Med. 200, 137–147.
Stokes, A. J., Wakano, C., Del Car-
men, K. A., Koblan-Huberson, M.,
and Turner, H. (2005). Formation
of a physiological complex between
TRPV2 and RGA protein promotes
cell surface expression of TRPV2. J.
Cell. Biochem. 94, 669–683.
Su, A. I., Wiltshire, T., Batalov, S., Lapp,
H., Ching, K. A., Block, D., et al.
(2004). A gene atlas of the mouse and
human protein-encoding transcrip-
tomes. Proc. Natl. Acad. Sci. U.S.A.
101, 6062–6067.
Sulk, M., Seeliger, S., Aubert, J., Schwab,
V. D., Cevikbas, F., Rivier, M., et al.
(2012). . Distribution and expres-
sionof non-neuronal transient recep-
tor potential (TRPV) ion channels
in rosacea. J. Invest. Dermatol. 132,
1253–1262.
Tedder, T. F., andEngel, P. (1994). CD20:
a regulator of cell-cycle progression
of B lymphocytes. Immunol. Today
15, 450–454.
Turner, H., del Carmen, K. A., and
Stokes, A. (2007). Link between
TRPV channels and mast cell func-
tion. Handb. Exp. Pharmacol. 179,
457–471.
Vig, M., and Kinet, J. P. (2009). Cal-
cium signaling in immune cells. Nat.
Immunol. 10, 21–27.
Yamashiro, K., Sasano, T., Tojo, K.,
Namekata, I., Kurokawa, J., Sawada,
N., et al. (2010). Role of tran-
sient receptor potential vanilloid 2 in
LPS-induced cytokine production in
macrophages. Biochem. Biophys. Res.
Commun. 398, 284–289.
Yuan, M., Kiertscher, S. M., Cheng,
Q., Zoumalan, R., Tashkin, D.
P., and Roth, M. D. (2002).
Delta 9-tetrahydrocannabinol regu-
lates Th1/Th2 cytokine balance in
activated human T cells. J. Neuroim-
munol. 133, 124–131.
Zhang, D., Spielmann, A., Wang,
L., Ding, G., Huang, F., Gu, Q.,
et al. (2012). Mast-cell degranulation
induced by physical stimuli involves
the activation of transient-receptor-
potential channel TRPV2. Physiol.
Res. 61, 113–124.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
Frontiers in Immunology | Inﬂammation February 2013 | Volume 4 | Article 34 | 8
“ﬁmmu-04-00034” — 2013/2/13 — 11:04 — page 9 — #9
Santoni et al. TRPV2 in immune responses
could be construed as a potential con-
ﬂict of interest.
Received: 13December 2012; paper pend-
ing published: 06 January 2013; accepted:
30 January 2013; published online: 14
February 2013.
Citation: Santoni G, Farfariello V,
Liberati S, Morelli MB, Nabissi M, San-
toni M and Amantini C (2013) The role
of transient receptor potential vanilloid
type-2 ion channels in innate and adap-
tive immune responses. Front. Immun.
4:34. doi: 10.3389/ﬁmmu.2013.00034
This article was submitted to Frontiers in
Inﬂammation, a specialty of Frontiers in
Immunology.
Copyright © 2013 Santoni, Farfariello,
Liberati, Morelli, Nabissi, Santoni and
Amantini. This is an open-access arti-
cle distributed under the terms of the
Creative Commons Attribution License,
which permits use, distribution and
reproduction in other forums, pro-
vided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
www.frontiersin.org February 2013 | Volume 4 | Article 34 | 9
